Bicycle Therapeutics plc (BCYC) Tops Q4 EPS by 65c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q4 EPS of ($0.29), $0.65 better than the analyst estimate of ($0.94). Revenue for the quarter came in at $47.95 million versus the consensus estimate of $7.04 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Marlin Business Services (MRLN) Reports Q2 Loss of $1.40